dimyristoylphosphatidylcholine has been researched along with 5,11-dimethyl-5h-indolo(2,3-b)quinoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godlewska, J; Gubernator, J; Kaczmarek, Ł; Kociubińska, A; Kozubek, A; Opolski, A; Peczyńska-Czoch, W; Stasiuk, M | 1 |
| Jaromin, A; Kaczmarek, L; Kozubek, A; Malicka-Blaszkiewicz, M; Peczynska-Czoch, W; Suchoszek-Lukaniuk, K | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and 5,11-dimethyl-5h-indolo(2,3-b)quinoline
| Article | Year |
|---|---|
A derivative of 5-H-indolo[2,3-b]quinoline--a novel liposomally-formulated anticancer agent.
Topics: Antineoplastic Agents; Carbolines; Dimyristoylphosphatidylcholine; Drug Carriers; Humans; Liposomes; Phosphatidylglycerols; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2002 |
Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b]quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Carbolines; Cell Shape; Cell Survival; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Drug Compounding; Glycerophospholipids; Hemolysis; Hydrogen-Ion Concentration; Liposomes; Liver Neoplasms, Experimental; Particle Size; Phosphatidylglycerols; Rats; Rats, Inbred BUF; Sheep; Tumor Cells, Cultured | 2008 |